Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
NCT06799481
Recruiting
This clinical trial evaluates the impact of a research intervention of virtually supervised exercise program (RISE) on cancer-related cognitive impairment (CRCI), physical activity in adolescent and young adult (AYA) brain tumor survivors. This clinical trial also evaluates the impact of RISE on the collection of microorganisms that exist in the intestines (gut microbiome). Up to 45% of AYA brain tumor survivors experience CRCI, including issues with attention and memory. CRCI can have a negativ... Read More
Gender:
ALL
Ages:
Between 15 years and 39 years
Trial Updated:
03/27/2025
Locations: Emory University Hospital, Atlanta, Georgia
Conditions: Cancer-related Cognitive Dysfunction, Primary Brain Neoplasm
Register for Updates
Neuromodulation and Neurorehabilitation for mTBI
NCT03819608
Recruiting
This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing training (APT) when combined with intermittent theta burst stimulation (iTBS), a type of repetitive transcranial magnetic stimulation and (ii) determine how APT + iTBS changes the neurocognitive system of attention in individuals with persistent attention deficits related to mTBI +/- PTSD.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
03/27/2025
Locations: Northwestern University, Chicago, Illinois +1 locations
Conditions: Mild Traumatic Brain Injury, Post Traumatic Stress Disorder
Register for Updates
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
NCT05255601
Recruiting
The purpose of this study is to assess the safety, tolerability, drug levels, and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma.
Gender:
ALL
Ages:
30 years and below
Trial Updated:
03/27/2025
Locations: Local Institution - 0077, Birmingham, Alabama +75 locations
Conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease
Register for Updates
Family, Responsibility, Education, Support, and Health for Families With a Child With Autism
NCT05741840
Recruiting
The objective of this proposed study is to collect initial efficacy data on a telehealth parent-based behavioral program for children with autism and overweight or obesity (PBT-A), compared with health education (HE).
Gender:
ALL
Ages:
Between 6 years and 12 years
Trial Updated:
03/27/2025
Locations: UC San Diego Center for Healthy Eating and Activity Research (CHEAR), La Jolla, California
Conditions: Autism Spectrum Disorder, Obesity, Childhood, Autism
Register for Updates
Client-Centered Care Coordination for Black Men Who Have Sex With Men
NCT06056544
Recruiting
The goal of this clinical trial is to determine the efficacy of a client-center care coordination intervention (C4) in improving pre-exposure prophylaxis (PrEP) adherence in Black men who have sex with men (MSM). The main aims of the study are: 1. Determine the efficacy of C4 for increasing PrEP adherence among Black MSM. 2. Identify the optimal dose of C4 implementation for maximizing its effect on PrEP adherence. 3. Describe the acceptability and feasibility of C4 implementation in community... Read More
Gender:
MALE
Ages:
18 years and above
Trial Updated:
03/27/2025
Locations: Us Helping Us, People Into Living Inc., Washington, District of Columbia
Conditions: HIV Prevention, HIV Pre-exposure Prophylaxis
Register for Updates
NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers
NCT06402565
Recruiting
The goal of this multi-center, randomized, controlled, evaluator-blinded study is to assess and measure the safety and efficacy of NOX1416 as an adjunct to standard of care (SOC) in the treatment of chronic, non-healing, diabetic foot ulcers (DFUs). Subjects will be randomized to receive treatment with NOX1416 as an adjunct to Standard of Care (SOC) or SOC alone. The primary objective of the study is to demonstrate the safety and tolerability of NOX1416 as adjunct to SOC. The secondary objectiv... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
03/27/2025
Locations: Prohealth Research Center, Doral, Florida +1 locations
Conditions: Diabetic Foot Ulcer
Register for Updates
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
NCT06653842
Recruiting
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX022 (sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
Gender:
ALL
Ages:
6 years and above
Trial Updated:
03/27/2025
Locations: Children's Hospital of Orange County, Irvine, California +9 locations
Conditions: Cutaneous Venous Malformations
Register for Updates
Smart Underwear to Measure Diet-Induced Hydrogen Sulfide Production
NCT06802276
Recruiting
The purpose of this study is to evaluate the ability of a wearable Smart Underwear prototype device to quantify diet-induced changes in gut microbial hydrogen sulfide (H₂S) production. The core design is a single-site, 2-period, crossover feeding study with 6-day diet periods and an approximately 11-day washout period. Participants are fed each of two isocaloric diets designed to contrast gut microbial H₂S production (i.e., a high cysteine vs. low cysteine diet), in a random order.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/27/2025
Locations: University of Colorado Anschutz Medical Campus, Aurora, Colorado
Conditions: Hydrogen Sulfide, Gastrointestinal Microbiome
Register for Updates
Comparison of Patient-reported Pain After Initial Archwire Placement
NCT03906422
Recruiting
Three different types of 'archwires' can be used in Orthodontic treatment, wire choice is decided by treating Orthodontist based on professional preference since research shows that all types are equally effective. It is possible that one type of wire engenders more patient discomfort. This study will compare the discomfort levels engendered by the three wire types to determine if there is one that induces the least amount.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
03/27/2025
Locations: University of Colorado School of Dental Medicine, Aurora, Colorado
Conditions: Orthodontic Discomfort, Pain, Orofacial
Register for Updates
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
NCT05269316
Recruiting
This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of IMP9064 as monotherapy or in combination with PARP inhibitor Senaparib in patients with advanced solid tumors
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/27/2025
Locations: Hackensack University Medical Center PARTNER, Hackensack, New Jersey +7 locations
Conditions: Solid Tumor, Advanced Solid Tumor
Register for Updates
Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds
NCT05758168
Recruiting
When patients have surgery on the head and face, stitches are the standard way to close the wound. Wounds always result in a scar, but doctors are always looking for ways to reduce scarring. Several studies have been done to test ways to close wounds that reduce scarring. One idea is to reduce the tension around the cut. One way to reduce tension is to stitch a small piece of a special gauze over the top of the regular stitches. This procedure is called a "tie-over bolster dressing." As the name... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/27/2025
Locations: University of California, Davis - Dermatology Department, Sacramento, California
Conditions: Scarring
Register for Updates
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
NCT06070350
Recruiting
The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood transfusion. The primary objective of the clinical trial is to determine the effectiveness of Low Titer Group O Whole Blood (LTOWB) compared to component therapy (CT), and Tranexamic Acid (TXA) compared to placebo in decreasing 24-hour all-cause mortality in children with traumatic life threatening hemorrhage.
Gender:
ALL
Ages:
17 years and below
Trial Updated:
03/27/2025
Locations: University of Arizona, Tucson, Arizona +22 locations
Conditions: Hemorrhagic Shock, Trauma Injury
Register for Updates